Fluoxetine and Suicidal Ideation—A Review of the Literature

References

• Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical predictor. Archives of General Psychiatry 1976; 33: 1193–1197
   PubMed Web of Science ®Google Scholar
• Balon R. Fluoxetine and preoccupation with suicide (letter). American Journal of Psychiatry 1991; 148: 1260
   Google Scholar
• Beasley C. M., Domseif J. C., Rosomworth J. C., Sayler M. E., Rampey A. H., Heiligenstein J. H., Thompson V. L., Murphy D. J., Masica D. N. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment of depression. British Medical Journal 1991; 303: 685–692
   PubMed Web of Science ®Google Scholar
• Renfield P., Hell R. C., Lesis S. P. Fluoxetine: a review of its psychodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986; 32: 481–508
   PubMedGoogle Scholar
• Rerkley R. B. Discussion of fluoxetine and suicidal tendencies (letter). American Journal of Psychiatry 1990; 147: 1572
   PubMedGoogle Scholar
• Hremner J. D. Fluoxetine in depressed patients: a comparison with imipramine. Journal of Clinical Psychiatry 1984; 45: 414–419
   PubMedGoogle Scholar
• Cohn J. B. A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 26–31
   PubMed Web of Science ®Google Scholar
• Chouinard G. A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 32–37
   PubMed Web of Science ®Google Scholar
• Chouinard G. Fluoxetine and preoccupation with suicide (letter). American Journal of Psychiatry 1991; 148: 1258–1259
   PubMedGoogle Scholar
• Cowen P. J. The role of 5-Hydroxytryptamine in the action of antidepressants. Depression Briefing 1991; 2: 215–218
   Google Scholar
• Damluji N. F., Ferguson J. M. Paradoxical worsening of depressive symptomatology caused by antidepressants. Journal of Clinical Psychopharmacology 1988; 8: 347–349
   PubMed Web of Science ®Google Scholar
• Dasgupta K. Additional cases of suicidal ideation associated with fluoxetine (letter). American Journal of Psychiatry 1990; 147: 1570
   PubMedGoogle Scholar
• Detre T. P., Jarecki H. G. Modern Psychiatric Treatment. Lippincott, Philadelphia, PA 1971
   Google Scholar
• Downs J., Ward J., Farmer R. Preoccupation with suicide in patients treated with fluoxetine (letter). American Journal of Psychiatry 1991; 148: 1090–1091
   PubMedGoogle Scholar
• Fava M., Rosenbaum J. F. Suicidality and fluoxetine: is there a relationship. Journal of Clinical Psychiatry 1991; 52: 108–111
   PubMed Web of Science ®Google Scholar
• Fetner H. H., Watts H. E., Geller B. Fluoxetine and preoccupation with suicide (letter). American Journal of Psychiatry 1991; 148: 1258
   PubMedGoogle Scholar
• Feuerstein T. J., Jackish R. Why do some antidepressants promote suicide (letter). Psychopharmacology (Berlin) 1980; 90: 422
   Google Scholar
• Fichtner C. G., Jobe T. H., Braun B. G. Does fluoxetine have a therapeutic window (letter). Lancet 1991; 338: 520–521
   PubMedGoogle Scholar
• Gorman J. M., Liebowitz M. R., Fyer A. J., Goetz D., Campeas R. B., Fyer M. R., Davies S. O., Klein D. F. An open trial of fluoxetine in the treatment of panic attacks. Journal of Clinical Psychopharmacology 1987; 7: 329–332
   PubMed Web of Science ®Google Scholar
• Hall R. C., Joffe J. R. Aberrant response to diazepam: a new syndrome. American Journal of Psychiatry 1972; 129: 114–118
   Web of Science ®Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967; 6: 278–296
   PubMed Web of Science ®Google Scholar
• Hierholzer R. Limitations of fluoxetine (letter). American Journal of Psychiatry 1990; 147: 1691
   PubMedGoogle Scholar
• Hoover C. E. Additional cases of suicidal ideation association with fluoxetine (letter). American Journal of Psychiatry 1990; 147: 1570–1571
   PubMedGoogle Scholar
• Hoover C. E. Suicidal ideation not associated with fluoxetine (letter). American Journal of Psychiatry 1991; 148: 542
   PubMedGoogle Scholar
• Johnson F. N. The chemistry of the brain. Depression Briefing 1991; 2: 201–212
   Google Scholar
• Johnson F. N., Freeman C. P. L. Fluoxetine, body weight and bulimia nervosa. Reviews in Contemporary Pharmacotherapy 1990; 1: 49–57
   Google Scholar
• King R. A., Riddle M. A., Chappell P. B., Hardin M. T., Anderson G. M., Lambroso P., Scahill L. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. Journal of the American Academy of Child and Adolescent Psychiatry 1991; 30: 179–185
   PubMed Web of Science ®Google Scholar
• Koizumi H. Fluoxetine and suicidal ideation (letter). Journal of the American Academy of child and Adolescent Psychiatry 1991; 30: 695
   PubMedGoogle Scholar
• Landry P., Chouinard G. Obsessive-compulsive disorder (OCD): pathogenesis and fluoxetine treatment. Reviews in Contemporary Pharmacotherapy 1990; 1: 61–70
   Google Scholar
• Levine S., Deo R., Mahadevan K. A comparative clinical trial of a new antidepressant. fluoxetine. British Journal of Psychiatry 1987; 150: 653–655
   PubMedGoogle Scholar
• Masand P., Gupta S., Dewan M. Suicidal ideation related to fluoxetine treatment (letter). New England Journal of Medicine 1991; 324: 420
   PubMed Web of Science ®Google Scholar
• McGrath B. J., Stoukides C. A. Fluoxetine and suicidal ideation. DICP -The Annals of Pharmacotherapy 1991; 25: 607–609
   PubMedGoogle Scholar
• Miller K. A. Discussion of fluoxetine and suicidal tendencies (letter). American Journal of Psychiatry 1990; 147: 1571
   PubMedGoogle Scholar
• Muijen M., Roy D., Silverstone T., Mehmet A., Christie M. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed patients. Acta Psychiatrica Scandinavica 1988; 78: 384–390
   PubMedGoogle Scholar
• Opler L. A. Fluoxetine and preoccupation with suicide (letter). American Journal of Psychiatry 1991; 148: 1259
   Google Scholar
• Papp L. A., Gorman J. M. Suicidal preoccupation during fluoxetine treatment (letter). American Journal of Psychiatry 1990; 147: 1380
   PubMed Web of Science ®Google Scholar
• Pearlman T. Fluoxetine and preoccupation with suicide (letter). American Journal of Psychiatry 1991; 148: 1258
   PubMedGoogle Scholar
• Rouillon F., Phillips K., Serrurier D., Ansart E., Gerard M. J. Rechutes de depression unipolaire et efficacite de la maprotiline. L'Encephale 1989; 15: 527–534
   PubMedGoogle Scholar
• Sacchetti E., Vita A., Guarneri L., Cornacchia M. The effectiveness of fluoxetine, clomipramine, nortriptyline and desipramine in major depressives with suicidal behaviour: preliminary findings. Serotonin-related psychiatric syndromes: clinical and therapeutic links, G. B. Cassano, H. S. Akiskal. Royal Society of Medicine, London 1991, (International Congress and Symposium Series No. 165)
   Google Scholar
• Soloff P. F., George A., Nathan R. S., Schulz P. M., Perel J. M. Paradoxical effects of amitriptyline in borderline patients. American Journal of Psychiatry 1986; 143: 1603–1605
   PubMed Web of Science ®Google Scholar
• Stark P., Hardison C. D. A review of multicentre controlled studies of fluoxetine versus imipramine and placebo in outpatients with major depressive disorder. Journal of Clinical Psychiatry 1985; 46: 53–58
   PubMed Web of Science ®Google Scholar
• Stone A. B., Pearltein T. B., Brown W. A. Fluoxetine and preoccupation with suicide. American Journal of Psychiatry 1991; 148: 1259–1260
   Google Scholar
• Teicher M. H., Glod C., Cole J. O. Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry 1990a; 147: 207–210
   PubMed Web of Science ®Google Scholar
• Teicher M. H., Glod C. A., Cole J. O. Suicidal preoccupation during fluoxetine treatment (reply). American Journal of Psychiatry 1990b; 147: 1380–1381
   PubMedGoogle Scholar
• Teicher M. H., Glod C., Cole J. O. Discussion of fluoxetine and suicidal tendencies (reply). American Journal of Psychiatry 1990c; 147: 1572
   PubMedGoogle Scholar
• Teicher M. H., God C. A., Cole J. O. Fluoxetine and suicidal ideation (reply). American Journal of Psychiatry 1990d; 147: 1692–1693
   Google Scholar
• Teicher M. H., Glod C. A., Cole J. O. Preoccupation with suicide in patients treated with fluoxetine (reply). American Journal of Psychiatry 1990a; 148: 1091
   Google Scholar
• Teicher M. H., Glod C. A., Cole J. O. Fluoxetine and preoccupation with suicide (reply). American Journal of Psychiatry 1991b; 148: 1260–1262
   Google Scholar
• Tollefson G. D. Fluoxetine and suicidal ideation (letter). American Journal of Psychiatry 1990; 147: 1691–1692
   PubMed Web of Science ®Google Scholar
• Wakelin J. S. The role of serotonin in depression and suicide: do serotonin reuptake inhibitors provide a key. Advances in Biological Psychiatry 1988; 17: 70–83
   Google Scholar
• Wernicke J. F. The side-effect profile and safety of fluoxetine. Journal of Clinical Psychiatry 1985; 46: 59–67
   PubMed Web of Science ®Google Scholar
• Wong D., Bymaster F. P. Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine. Research Communications in Chemical Pathology and Pharmacology 1981; 32: 41–51
   PubMedGoogle Scholar